These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11820865)

  • 21. Acute effects of heparin administration on the ischemic threshold of patients with coronary artery disease: evaluation of the protective role of the metabolic modulator trimetazidine.
    Fragasso G; Piatti PM; Monti L; Palloshi A; Lu C; Valsecchi G; Setola E; Calori G; Pozza G; Margonato A; Chierchia S
    J Am Coll Cardiol; 2002 Feb; 39(3):413-9. PubMed ID: 11823078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trimetazidine inhibits mitochondrial permeability transition pore opening and prevents lethal ischemia-reperfusion injury.
    Argaud L; Gomez L; Gateau-Roesch O; Couture-Lepetit E; Loufouat J; Robert D; Ovize M
    J Mol Cell Cardiol; 2005 Dec; 39(6):893-9. PubMed ID: 16243351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of trimetazidine on myocardial perfusion and left ventricular systolic function in type 2 diabetic patients with ischemic cardiomyopathy.
    Belardinelli R; Cianci G; Gigli M; Mazzanti M; Lacalaprice F
    J Cardiovasc Pharmacol; 2008 Jun; 51(6):611-5. PubMed ID: 18574390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trimetazidine improves exercise performance in patients with peripheral arterial disease.
    Vitale C; Marazzi G; Pelliccia F; Volterrani M; Cerquetani E; Spoletini I; Mercuro G; Bonassi S; Dall'Armi V; Fini M; Rosano GM
    Pharmacol Res; 2011 Apr; 63(4):278-83. PubMed ID: 21220024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of trimetazidine on heart rate variability in patients with slow coronary artery flow.
    Topal E; Ozdemir R; Barutcu I; Aksoy Y; Sincer I; Akturk E; Cehreli S
    J Electrocardiol; 2006 Apr; 39(2):211-8. PubMed ID: 16580422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of protective effects of trimetazidine against experimental warm ischemia of different durations: early and long-term effects in a pig kidney model.
    Jayle C; Favreau F; Zhang K; Doucet C; Goujon JM; Hebrard W; Carretier M; Eugene M; Mauco G; Tillement JP; Hauet T
    Am J Physiol Renal Physiol; 2007 Mar; 292(3):F1082-93. PubMed ID: 17341718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of trimetazidine in cardiovascular disease: beyond an anti-anginal agent.
    McCarthy CP; Mullins KV; Kerins DM
    Eur Heart J Cardiovasc Pharmacother; 2016 Oct; 2(4):266-72. PubMed ID: 27533944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction of postoperative adhesions by trimetazidine: an experimental study in a rat model.
    Erdemoglu E; Seçkin B; Günyeli I; Güney M; Seçkin M; Mungan T
    Arch Gynecol Obstet; 2012 Mar; 285(3):757-61. PubMed ID: 21909751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Decrease in the sensitivity to the anti-ischemic effect of propranolol and prospects for correcting it in patients with stable angina pectoris].
    Butina EK; Kokurina EV; Dmitrieva NA; Bochkareva EV
    Ter Arkh; 2002; 74(9):36-41. PubMed ID: 12418118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trimetazidine in geriatric patients with stable angina pectoris: the tiger study.
    Kölbel F; Bada V
    Int J Clin Pract; 2003 Dec; 57(10):867-70. PubMed ID: 14712887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The PRIMA study: trimetazidin in the treatment of patients with stable angina pectoris after myocardial infarction. Epidemiological and clinical phases].
    Vasiuk IuA; Shal'nova SA; Shkol'nik EL; Kulikov KG
    Kardiologiia; 2008; 48(12):10-3. PubMed ID: 19076088
    [No Abstract]   [Full Text] [Related]  

  • 32. Suppression of angioplasty-related inflammation by pre-procedural treatment with trimetazidine.
    Kuralay F; Altekin E; Yazlar AS; Onvural B; Goldeli O
    Tohoku J Exp Med; 2006 Mar; 208(3):203-12. PubMed ID: 16498228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trimetazidine in the prevention of contrast-induced nephropathy after coronary procedures.
    Onbasili AO; Yeniceriglu Y; Agaoglu P; Karul A; Tekten T; Akar H; Discigil G
    Heart; 2007 Jun; 93(6):698-702. PubMed ID: 17065180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinicopathogenetic features of coronary heart disease combined with chronic obstructive pulmonary diseases and efficiency of therapy with trimetazidin].
    Kolomoets NM; Baksheev VI; Uvaĭsova KU
    Klin Med (Mosk); 2008; 86(6):38-43. PubMed ID: 18720710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effects of trimetazidine on vascular smooth muscle cell and endothelial cell in response to carotid artery balloon injury in diabetic rats.
    Yoon JW; Cho BJ; Park HS; Kang SM; Choi SH; Jang HC; Shin H; Lee MJ; Kim YB; Park KS; Lim S
    Int J Cardiol; 2013 Jul; 167(1):126-33. PubMed ID: 22240760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trimetazidine exerts protection against increasing current electroshock seizure test in mice.
    Jain S; Bharal N; Mediratta PK; Sharma KK
    Seizure; 2010 Jun; 19(5):300-2. PubMed ID: 20444628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of trimetazidine in angina pectoris by echocardiography and radionuclide angiography: a meta-analysis of randomized, controlled trials.
    Hu B; Li W; Xu T; Chen T; Guo J
    Clin Cardiol; 2011 Jun; 34(6):395-400. PubMed ID: 21538382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic value of a cardioprotective agent in patients with severe ischaemic cardiomyopathy.
    Brottier L; Barat JL; Combe C; Boussens B; Bonnet J; Bricaud H
    Eur Heart J; 1990 Mar; 11(3):207-12. PubMed ID: 2318223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of the myocardial protection of trimetazidine during percutaneous coronary intervention: a multi-center randomized and controlled clinical study].
    Chen YD; Zhao LK; Tian F; Du ZM; Jiang H; Wei M
    Zhonghua Nei Ke Za Zhi; 2010 Jun; 49(6):473-6. PubMed ID: 20979731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapeutic value of trimetazidine in patients with coronary heart disease and left ventricular dysfunction].
    Multicentral Collaborative Group on Trimetazidine (Phase IV)
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Sep; 33(9):793-5. PubMed ID: 16266453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.